Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Australian Firm Genetic Signatures to Enter US Market With Syndromic Kit for GI Conditions

Australian Firm Genetic Signatures to Enter US Market With Syndromic Kit for GI Conditions

Jan 09, 2020
|
Leo O'Connor
Premium

NEW YORK – On the heels of a $25 million financing round, Australian diagnostic instrument and test developer Genetic Signatures is expanding its European and US marketing and sales operations and preparing an application to the US Food and Drug Administration for clearance of a syndromic enteric protozoa kit.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Earlier in the US

An analysis of blood donations suggests SARS-CoV-2 was present in the US weeks earlier than thought, according to NPR.

How the Proteins Shape Up

The Guardian reports that DeepMind Technologies' AlphaFold can predict how proteins fold.

Who's to Be First?

CNBC reports that a US Centers for Disease Control and Prevention advisory panel is to vote on how to distribute COVID-19 vaccines.

PNAS Papers on Ovarian Cancer, Retrotransposon Insertions in Cancer, Malaria Mosquitoes

In PNAS this week: targeting progesterone signaling in ovarian cancer, LINE-1 retrotransposition events in adenocarcinomas, and more.

Dec
03
Featured Webinar

Leveraging Multi-Omic Approaches to Understand Disease Stem Cells in Myeloid Malignancies

Sponsored by
Mission Bio

Recent work by many investigators has discovered that over the course of aging, hematopoietic stem cells (HSCs) commonly undergo clonal expansion. 

What's Popular?

In Molecular Diagnostics

  1. Grail Inks Deal With UK National Health Service to Offer Cancer Screening Blood Test in 2021

  2. European Consortium Seeks to Develop Liquid Biopsy Test for Prostate, Testicular Cancer

    Premium

  3. Progenity to Raise $100M in Separate Public Stock, Private Senior Notes Offerings

  4. Cepheid, Roche Coronavirus Tests Get FDA Emergency Use Authorization

  5. Startup Angstrom Bio Plans Saliva-Based COVID-19 Nucleic Acid Test on Nanopore Sequencing Platform

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.